Protirelin Tartrate Hydrate Injection 0.5mg (Hirtonin® / ヒルトニン0.5mg注射液)

JPY ¥7,800

Japanese Prolonged Disturbance of Consciousness / Spinocerebellar Degeneration Treatment / TSH Function Test Agent (Protirelin Tartrate Hydrate 0.5mg/1mL). For intravenous, intramuscular, or subcutaneous injection. 1mL x 10 ampoules. Mfd. by T’s Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥7,176
10 - 19 12% JPY ¥6,864
20 + 18% JPY ¥6,396
SKU: HIR-05-INJ Category:

Description

Product Overview / 商品概要

Hirtonin 0.5mg Injection (ヒルトニン0.5mg注射液)
Generic: Protirelin Tartrate Hydrate / プロチレリン酒石酸塩水和物
Therapeutic Category: Prolonged Disturbance of Consciousness Treatment Agent / Spinocerebellar Degeneration Treatment Agent / TSH Secretion Function Test Agent / 遷延性意識障害治療剤・脊髄小脳変性症治療剤・TSH分泌機能検査用剤
Manufactured by: T’s Pharmaceutical Co., Ltd. / T’s製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Protirelin Tartrate Hydrate 0.732mg (equivalent to Protirelin 0.5mg) per 1 ampoule (1mL) / 1アンプル(1mL)中:プロチレリン酒石酸塩水和物 0.732mg(プロチレリンとして0.5mg)
Additives: D-Sorbitol (50mg), pH adjuster / D-ソルビトール(50mg)、pH調節剤
Appearance: Colorless clear solution; pH 5.5–6.5; osmolarity ratio approximately 1 (relative to physiological saline)
外観: 無色澄明の液、pH 5.5~6.5、浸透圧比 約1(生理食塩液に対する比)

Indications / 効能効果

EN: Prolonged disturbance of consciousness (excluding coma and semi-coma) associated with the following conditions: head trauma; subarachnoid hemorrhage (only within 3 weeks of consciousness disturbance fixation). Improvement of ataxia in spinocerebellar degeneration. Pituitary TSH secretion function test.
JA: ○下記疾患に伴う昏睡、半昏睡を除く遷延性意識障害・頭部外傷・くも膜下出血、ただし意識障害固定期間3週以内○脊髄小脳変性症における運動失調の改善○下垂体TSH分泌機能検査

Dosage and Administration / 用法用量

EN: Prolonged disturbance of consciousness: Administer once daily for 10 days by intravenous injection or intravenous drip infusion. For IV injection, dilute in 5–10mL of physiological saline, glucose injection, or water for injection and inject slowly. 1) Head trauma: 0.732–2.92mg as protirelin tartrate hydrate (0.5–2mg as protirelin) per dose. 2) Subarachnoid hemorrhage (within 3 weeks of consciousness fixation): 2.92mg as protirelin tartrate hydrate (2mg as protirelin) per dose. Spinocerebellar degeneration: Administer 0.732–2.92mg as protirelin tartrate hydrate (0.5–2mg as protirelin) once daily by intramuscular or intravenous injection. In severe cases, 2.92mg as protirelin tartrate hydrate (2mg as protirelin). Administer daily for 2–3 weeks, followed by a 2–3 week rest period; repeat or switch to intermittent injection 2–3 times per week. For IV injection, dilute in 5–10mL of physiological saline, glucose injection, or water for injection and inject slowly. Pituitary TSH secretion function test: Administer 0.732mg as protirelin tartrate hydrate (0.5mg as protirelin) once by intravenous or subcutaneous injection. For IV injection, dilute in 5–10mL of physiological saline or water for injection and inject slowly.
JA: 〈遷延性意識障害〉通常、成人には疾患に応じて下記の用量を1日1回10日間静注又は点滴静注する。静脈内注射の場合は、生理食塩液、ブドウ糖注射液又は注射用水5~10mLに希釈して、徐々に注射する。1)頭部外傷:1回プロチレリン酒石酸塩水和物として0.732~2.92mg(プロチレリンとして0.5~2mg)2)くも膜下出血(意識障害固定期間3週以内):1回プロチレリン酒石酸塩水和物として2.92mg(プロチレリンとして2mg)〈脊髄小脳変性症〉通常、成人には1日1回プロチレリン酒石酸塩水和物として0.732~2.92mg(プロチレリンとして0.5~2mg)を筋肉内又は静脈内に注射する。重症例にはプロチレリン酒石酸塩水和物として2.92mg(プロチレリンとして2mg)を注射する。2~3週間連日注射した後、2~3週間の休薬期間をおく。以後、これを反復するか、週2~3回の間歇注射を行う。静脈内注射の場合は、生理食塩液、ブドウ糖注射液又は注射用水5~10mLに希釈して、徐々に注射する。〈下垂体TSH分泌機能検査〉通常、成人には1回プロチレリン酒石酸塩水和物0.732mg(プロチレリンとして0.5mg)を静脈内又は皮下に注射する。静脈内注射の場合は、生理食塩液あるいは注射用水5~10mLに希釈して、徐々に注射する。

Contraindications / 禁忌

EN: No contraindications explicitly stated in the package insert
JA: 添付文書に明示された禁忌の記載なし

Regulatory Information / 規制情報

Approval No.: 21300AMZ00656
Sales Started: March 1978 / 1978年3月
Classification Code: 87119、877223
Storage: Store at room temperature / 室温保存
Shelf Life: 4 years / 4年

Packaging / 包装

Main Package (for sale): 1mL x 10 ampoules / 1mL×10アンプル
Other Available Packages (by special order): 1mL x 10 ampoules

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Protirelin Tartrate Hydrate Injection 0.5mg (Hirtonin® / ヒルトニン0.5mg注射液)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Protirelin Tartrate Hydrate Injection 0.5mg (Hirtonin®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.